Loading…
The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure
Background Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD. Objective The objective of our study was to assess the experi...
Saved in:
Published in: | Movement disorders 2023-06, Vol.38 (6), p.1089-1093 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553 |
---|---|
cites | cdi_FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553 |
container_end_page | 1093 |
container_issue | 6 |
container_start_page | 1089 |
container_title | Movement disorders |
container_volume | 38 |
creator | Pérez‐Carbonell, Laura Simonet, Cristina Chohan, Harneek Gill, Aneet Leschziner, Guy Schrag, Anette Noyce, Alastair J. |
description | Background
Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD.
Objective
The objective of our study was to assess the experiences of risk disclosure in a group of patients with iRBD and their views on what, when, and how this should be done.
Methods
A survey was administered to patients with iRBD to explore their experiences and views on risk disclosure.
Results
Thirty‐one patients with iRBD (28 males; mean age, 70 [SD 8.7] years; mean disease duration, 8.7 [SD 6.4] years) were included. A third reported they had not been informed about the link between iRBD and other conditions by clinicians at diagnosis, but 90% would have liked to have received prognostic information, and 60% indicated that this should happen at the point that iRBD was diagnosed. Most participants wanted this information to come from the clinician diagnosing and treating iRBD (90.3%). Almost three‐quarters (72.2%) had searched for this information online.
Conclusions
Patients with iRBD mostly wished to have received information regarding the potential implications of iRBD when the diagnosis was made. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. |
doi_str_mv | 10.1002/mds.29403 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10947281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2800629221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhi0EokvhwB9AlrjAIe34K4lPCNoClVqB2sLVcuIJ65LEi53sav89XrZUgMRppJlHj97RS8hzBkcMgB8PLh1xLUE8IAumBCtqrqqHZAF1rQrBanVAnqR0C8CYYuVjciAqkKUEvSD2Zon0q8dNoqGjn-3kcZwS3fhpSc9T6O2Ejl7ZlXf0bIv0MqxxyAS97hFX9B0u7dqHSE99CtFhpGGkVz593y3aPqQ54lPyqLN9wmd385B8eX92c_KxuPj04fzk7UXRSilF0TFEq5oOG1057awsG91wKPOmY0JwBRylZtJWpShla3UjmK5dY0HbxiklDsmbvXc1NwO6NqeMtjer6AcbtyZYb_6-jH5pvoW1YaBlxWuWDa_uDDH8mDFNZshfYN_bEcOcDK8BSq4536Ev_0FvwxzH_F-mJDApag6Zer2n2hhSitjdp2Fgds2Z3Jz51VxmX_wZ_578XVUGjvfAxve4_b_JXJ5e75U_AXLzoy8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2840143820</pqid></control><display><type>article</type><title>The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure</title><source>Wiley</source><creator>Pérez‐Carbonell, Laura ; Simonet, Cristina ; Chohan, Harneek ; Gill, Aneet ; Leschziner, Guy ; Schrag, Anette ; Noyce, Alastair J.</creator><creatorcontrib>Pérez‐Carbonell, Laura ; Simonet, Cristina ; Chohan, Harneek ; Gill, Aneet ; Leschziner, Guy ; Schrag, Anette ; Noyce, Alastair J.</creatorcontrib><description>Background
Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD.
Objective
The objective of our study was to assess the experiences of risk disclosure in a group of patients with iRBD and their views on what, when, and how this should be done.
Methods
A survey was administered to patients with iRBD to explore their experiences and views on risk disclosure.
Results
Thirty‐one patients with iRBD (28 males; mean age, 70 [SD 8.7] years; mean disease duration, 8.7 [SD 6.4] years) were included. A third reported they had not been informed about the link between iRBD and other conditions by clinicians at diagnosis, but 90% would have liked to have received prognostic information, and 60% indicated that this should happen at the point that iRBD was diagnosed. Most participants wanted this information to come from the clinician diagnosing and treating iRBD (90.3%). Almost three‐quarters (72.2%) had searched for this information online.
Conclusions
Patients with iRBD mostly wished to have received information regarding the potential implications of iRBD when the diagnosis was made. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.29403</identifier><identifier>PMID: 37046409</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Aged ; autonomy ; Behavior disorders ; Brief Report ; Brief Reports ; Diagnosis ; Disclosure ; Eye movements ; Humans ; isolated REM sleep behavior disorder ; Male ; Movement disorders ; Neurodegenerative diseases ; Parkinson Disease - complications ; Parkinson Disease - diagnosis ; Parkinson Disease - epidemiology ; Parkinson's disease ; Polysomnography ; REM sleep ; REM Sleep Behavior Disorder - complications ; REM Sleep Behavior Disorder - diagnosis ; risk disclosure ; Sleep disorders ; Synucleinopathies</subject><ispartof>Movement disorders, 2023-06, Vol.38 (6), p.1089-1093</ispartof><rights>2023 The Authors. published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</rights><rights>2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553</citedby><cites>FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553</cites><orcidid>0000-0003-3027-5497 ; 0000-0002-5555-0283 ; 0000-0002-9872-6680 ; 0000-0002-1252-6742</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37046409$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pérez‐Carbonell, Laura</creatorcontrib><creatorcontrib>Simonet, Cristina</creatorcontrib><creatorcontrib>Chohan, Harneek</creatorcontrib><creatorcontrib>Gill, Aneet</creatorcontrib><creatorcontrib>Leschziner, Guy</creatorcontrib><creatorcontrib>Schrag, Anette</creatorcontrib><creatorcontrib>Noyce, Alastair J.</creatorcontrib><title>The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure</title><title>Movement disorders</title><addtitle>Mov Disord</addtitle><description>Background
Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD.
Objective
The objective of our study was to assess the experiences of risk disclosure in a group of patients with iRBD and their views on what, when, and how this should be done.
Methods
A survey was administered to patients with iRBD to explore their experiences and views on risk disclosure.
Results
Thirty‐one patients with iRBD (28 males; mean age, 70 [SD 8.7] years; mean disease duration, 8.7 [SD 6.4] years) were included. A third reported they had not been informed about the link between iRBD and other conditions by clinicians at diagnosis, but 90% would have liked to have received prognostic information, and 60% indicated that this should happen at the point that iRBD was diagnosed. Most participants wanted this information to come from the clinician diagnosing and treating iRBD (90.3%). Almost three‐quarters (72.2%) had searched for this information online.
Conclusions
Patients with iRBD mostly wished to have received information regarding the potential implications of iRBD when the diagnosis was made. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</description><subject>Aged</subject><subject>autonomy</subject><subject>Behavior disorders</subject><subject>Brief Report</subject><subject>Brief Reports</subject><subject>Diagnosis</subject><subject>Disclosure</subject><subject>Eye movements</subject><subject>Humans</subject><subject>isolated REM sleep behavior disorder</subject><subject>Male</subject><subject>Movement disorders</subject><subject>Neurodegenerative diseases</subject><subject>Parkinson Disease - complications</subject><subject>Parkinson Disease - diagnosis</subject><subject>Parkinson Disease - epidemiology</subject><subject>Parkinson's disease</subject><subject>Polysomnography</subject><subject>REM sleep</subject><subject>REM Sleep Behavior Disorder - complications</subject><subject>REM Sleep Behavior Disorder - diagnosis</subject><subject>risk disclosure</subject><subject>Sleep disorders</subject><subject>Synucleinopathies</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kU1v1DAQhi0EokvhwB9AlrjAIe34K4lPCNoClVqB2sLVcuIJ65LEi53sav89XrZUgMRppJlHj97RS8hzBkcMgB8PLh1xLUE8IAumBCtqrqqHZAF1rQrBanVAnqR0C8CYYuVjciAqkKUEvSD2Zon0q8dNoqGjn-3kcZwS3fhpSc9T6O2Ejl7ZlXf0bIv0MqxxyAS97hFX9B0u7dqHSE99CtFhpGGkVz593y3aPqQ54lPyqLN9wmd385B8eX92c_KxuPj04fzk7UXRSilF0TFEq5oOG1057awsG91wKPOmY0JwBRylZtJWpShla3UjmK5dY0HbxiklDsmbvXc1NwO6NqeMtjer6AcbtyZYb_6-jH5pvoW1YaBlxWuWDa_uDDH8mDFNZshfYN_bEcOcDK8BSq4536Ev_0FvwxzH_F-mJDApag6Zer2n2hhSitjdp2Fgds2Z3Jz51VxmX_wZ_578XVUGjvfAxve4_b_JXJ5e75U_AXLzoy8</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Pérez‐Carbonell, Laura</creator><creator>Simonet, Cristina</creator><creator>Chohan, Harneek</creator><creator>Gill, Aneet</creator><creator>Leschziner, Guy</creator><creator>Schrag, Anette</creator><creator>Noyce, Alastair J.</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3027-5497</orcidid><orcidid>https://orcid.org/0000-0002-5555-0283</orcidid><orcidid>https://orcid.org/0000-0002-9872-6680</orcidid><orcidid>https://orcid.org/0000-0002-1252-6742</orcidid></search><sort><creationdate>202306</creationdate><title>The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure</title><author>Pérez‐Carbonell, Laura ; Simonet, Cristina ; Chohan, Harneek ; Gill, Aneet ; Leschziner, Guy ; Schrag, Anette ; Noyce, Alastair J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Aged</topic><topic>autonomy</topic><topic>Behavior disorders</topic><topic>Brief Report</topic><topic>Brief Reports</topic><topic>Diagnosis</topic><topic>Disclosure</topic><topic>Eye movements</topic><topic>Humans</topic><topic>isolated REM sleep behavior disorder</topic><topic>Male</topic><topic>Movement disorders</topic><topic>Neurodegenerative diseases</topic><topic>Parkinson Disease - complications</topic><topic>Parkinson Disease - diagnosis</topic><topic>Parkinson Disease - epidemiology</topic><topic>Parkinson's disease</topic><topic>Polysomnography</topic><topic>REM sleep</topic><topic>REM Sleep Behavior Disorder - complications</topic><topic>REM Sleep Behavior Disorder - diagnosis</topic><topic>risk disclosure</topic><topic>Sleep disorders</topic><topic>Synucleinopathies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pérez‐Carbonell, Laura</creatorcontrib><creatorcontrib>Simonet, Cristina</creatorcontrib><creatorcontrib>Chohan, Harneek</creatorcontrib><creatorcontrib>Gill, Aneet</creatorcontrib><creatorcontrib>Leschziner, Guy</creatorcontrib><creatorcontrib>Schrag, Anette</creatorcontrib><creatorcontrib>Noyce, Alastair J.</creatorcontrib><collection>Wiley-Blackwell Titles (Open access)</collection><collection>Wiley-Blackwell Open Access Backfiles (Open Access)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pérez‐Carbonell, Laura</au><au>Simonet, Cristina</au><au>Chohan, Harneek</au><au>Gill, Aneet</au><au>Leschziner, Guy</au><au>Schrag, Anette</au><au>Noyce, Alastair J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov Disord</addtitle><date>2023-06</date><risdate>2023</risdate><volume>38</volume><issue>6</issue><spage>1089</spage><epage>1093</epage><pages>1089-1093</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><abstract>Background
Isolated rapid eye movement sleep behavior disorder (iRBD) is associated with an increased risk of Parkinson's disease and other synucleinopathies. There is no consensus about disclosure of this risk to patients with iRBD.
Objective
The objective of our study was to assess the experiences of risk disclosure in a group of patients with iRBD and their views on what, when, and how this should be done.
Methods
A survey was administered to patients with iRBD to explore their experiences and views on risk disclosure.
Results
Thirty‐one patients with iRBD (28 males; mean age, 70 [SD 8.7] years; mean disease duration, 8.7 [SD 6.4] years) were included. A third reported they had not been informed about the link between iRBD and other conditions by clinicians at diagnosis, but 90% would have liked to have received prognostic information, and 60% indicated that this should happen at the point that iRBD was diagnosed. Most participants wanted this information to come from the clinician diagnosing and treating iRBD (90.3%). Almost three‐quarters (72.2%) had searched for this information online.
Conclusions
Patients with iRBD mostly wished to have received information regarding the potential implications of iRBD when the diagnosis was made. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>37046409</pmid><doi>10.1002/mds.29403</doi><tpages>28</tpages><orcidid>https://orcid.org/0000-0003-3027-5497</orcidid><orcidid>https://orcid.org/0000-0002-5555-0283</orcidid><orcidid>https://orcid.org/0000-0002-9872-6680</orcidid><orcidid>https://orcid.org/0000-0002-1252-6742</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3185 |
ispartof | Movement disorders, 2023-06, Vol.38 (6), p.1089-1093 |
issn | 0885-3185 1531-8257 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10947281 |
source | Wiley |
subjects | Aged autonomy Behavior disorders Brief Report Brief Reports Diagnosis Disclosure Eye movements Humans isolated REM sleep behavior disorder Male Movement disorders Neurodegenerative diseases Parkinson Disease - complications Parkinson Disease - diagnosis Parkinson Disease - epidemiology Parkinson's disease Polysomnography REM sleep REM Sleep Behavior Disorder - complications REM Sleep Behavior Disorder - diagnosis risk disclosure Sleep disorders Synucleinopathies |
title | The Views of Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder on Risk Disclosure |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A39%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Views%20of%20Patients%20with%20Isolated%20Rapid%20Eye%20Movement%20Sleep%20Behavior%20Disorder%20on%20Risk%20Disclosure&rft.jtitle=Movement%20disorders&rft.au=P%C3%A9rez%E2%80%90Carbonell,%20Laura&rft.date=2023-06&rft.volume=38&rft.issue=6&rft.spage=1089&rft.epage=1093&rft.pages=1089-1093&rft.issn=0885-3185&rft.eissn=1531-8257&rft_id=info:doi/10.1002/mds.29403&rft_dat=%3Cproquest_pubme%3E2800629221%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4443-f1eea5bfeb97d9da46b9b206bfef1332502e4914a76364ca9b3198dba09abd553%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2840143820&rft_id=info:pmid/37046409&rfr_iscdi=true |